Gustav Gaudernack

Gustav Gaudernack

UNVERIFIED PROFILE

Are you Gustav Gaudernack?   Register this Author

Register author
Gustav Gaudernack

Gustav Gaudernack

Publications by authors named "Gustav Gaudernack"

Are you Gustav Gaudernack?   Register this Author

54Publications

946Reads

13Profile Views

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Cancer Immunol Immunother 2020 01;69(1):159-161

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02409-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949204PMC
January 2020

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.

Cancer Immunol Immunother 2019 Aug 18;68(8):1235-1243. Epub 2019 Jun 18.

Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02356-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682583PMC
August 2019

NK cells specifically TCR-dressed to kill cancer cells.

EBioMedicine 2019 Feb 18;40:106-117. Epub 2019 Jan 18.

Department of Cellular Therapy, Department for Cancer Therapy, Oslo University Hospital Radiumhospitalet, Oslo 0379, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.01.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413353PMC
February 2019

A TCR-based Chimeric Antigen Receptor.

Sci Rep 2017 09 6;7(1):10713. Epub 2017 Sep 6.

Department for Cellular Therapy, Department for Cancer Therapy, Oslo University Hospital Radiumhospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-11126-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587706PMC
September 2017

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.

Cancer Immunol Immunother 2017 Jul 8;66(7):891-901. Epub 2017 Apr 8.

Department of Cellular Therapy, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-017-1994-y
Publisher Site
http://dx.doi.org/10.1007/s00262-017-1994-yDOI Listing
July 2017

T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces tumor growth.

Oncoimmunology 2017 17;6(4):e1302631. Epub 2017 Mar 17.

Section for Cancer Immunology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1302631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414866PMC
March 2017

Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency.

Cancer Res 2016 08 3;76(15):4347-58. Epub 2016 Jun 3.

Department of Dermatology, University Hospital Essen, University Duisburg-Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-0008DOI Listing
August 2016

Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination.

Cancer Immunol Immunother 2015 Dec 26;64(12):1609-21. Epub 2015 Oct 26.

Department of Immunology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-015-1766-5DOI Listing
December 2015

Therapeutic vaccines for cancer: an overview of clinical trials.

Nat Rev Clin Oncol 2014 Sep 8;11(9):509-24. Epub 2014 Jul 8.

Cancer Centre Karolinska, Department of Oncology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.111DOI Listing
September 2014

Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.

Int J Cancer 2014 Jan 16;134(1):102-13. Epub 2013 Jul 16.

Department of Clinical Analysis and Immunology, University Hospital Virgen de las Nieves, Granada, Spain; Department of Biochemistry, Molecular Biology III and Immunology, University of Granada Medical School, Granada, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28338DOI Listing
January 2014

Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab.

Leuk Lymphoma 2013 Oct 2;54(10):2205-14. Epub 2013 Apr 2.

Division for Surgery and Cancer Medicine, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital , Oslo , Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.774392DOI Listing
October 2013

In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines.

Exp Hematol Oncol 2013 Jun 6;2(1):16. Epub 2013 Jun 6.

Department of Cellular Therapy, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2162-3619-2-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734134PMC
June 2013

Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.

Leuk Lymphoma 2012 Oct 22;53(10):1934-44. Epub 2012 May 22.

Division for Surgery and Cancer Medicine, Institute for Cancer Research, The Norwegian Radium Hospital and Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.682307DOI Listing
October 2012

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001.

Oncoimmunology 2012 Aug;1(5):670-686

Unit for Immunotherapy; Section for Immunology; Institute for Cancer Research; Oslo University Hospital; Norwegian Radium Hospital; Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.20426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429571PMC
August 2012

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides.

Cancer Immunol Immunother 2011 Nov 17;60(11):1553-64. Epub 2011 Jun 17.

Department of Dermatology, University of Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-011-1061-zDOI Listing
November 2011

Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.

Clin Cancer Res 2011 Nov 14;17(21):6847-57. Epub 2011 Sep 14.

Department of Clinical Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1385DOI Listing
November 2011

Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients.

Clin Cancer Res 2011 Jul 17;17(13):4568-80. Epub 2011 May 17.

Section for Clinical Cancer Research, Department of Oncology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0184DOI Listing
July 2011

hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes.

Cancer Immunol Immunother 2011 Jun 2;60(6):809-18. Epub 2011 Mar 2.

Section for Immunology, Oslo University Hospital and University of Oslo, Radiumhospitalet, Montebello, 0310, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-011-0991-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098983PMC
June 2011

Transiently redirected T cells for adoptive transfer.

Cytotherapy 2011 May 21;13(5):629-40. Epub 2010 Dec 21.

Section for Immunology, Radiumhospitalet, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/14653249.2010.542461DOI Listing
May 2011

Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy.

J Immunol Methods 2010 Apr 19;355(1-2):52-60. Epub 2010 Feb 19.

Department of Immunology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2010.02.004DOI Listing
April 2010

Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3.

Ultrastruct Pathol 2009 Jul-Aug;33(4):175-81

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Henan, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01913120903086072DOI Listing
November 2009

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.

Cancer Immunol Immunother 2009 Oct 17;58(10):1609-26. Epub 2009 Feb 17.

Section for Immunotherapy, Department of Immunology, Cancer Research Institute, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Medical Faculty, University of Oslo, 0310, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0670-2DOI Listing
October 2009

EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase.

Cell Signal 2008 Jun 10;20(6):1169-78. Epub 2008 Apr 10.

Department of Biochemistry, Institute of Basic Medical Sciences, University of Oslo, N-0317 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2008.02.007DOI Listing
June 2008

Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.

J Immunol Methods 2008 Jan 20;330(1-2):12-23. Epub 2007 Nov 20.

Department of Immunology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Montebello, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2007.10.011DOI Listing
January 2008

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.

Cancer Immunol Immunother 2007 May 1;56(5):659-75. Epub 2006 Sep 1.

Section for Immunotherapy, Department of Immunology, Cancer Research Institute, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-006-0222-yDOI Listing
May 2007

Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.

Cancer Immunol Immunother 2006 Nov 13;55(11):1432-42. Epub 2006 Apr 13.

Section for Immunotherapy, Department of Immunology, Cancer Research Institute, The Norwegian Radium Hospital, University of Oslo, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-006-0161-7DOI Listing
November 2006

Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.

BMC Mol Biol 2006 Aug 29;7:26. Epub 2006 Aug 29.

Section for Immunotherapy, Department of Immunology, The Norwegian Radium Hospital, Cancer Research Institute, University of Oslo, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2199-7-26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560392PMC
August 2006

Prospects for vaccine therapy for pancreatic cancer.

Best Pract Res Clin Gastroenterol 2006 Apr;20(2):299-314

Section for Immunotherapy, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2006.01.003DOI Listing
April 2006

Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination.

Cancer Gene Ther 2005 Jun;12(6):579-91

Section for Immunotherapy, Department of Immunology, Cancer Research Institute, The Norwegian Radium Hospital, University of Oslo, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.cgt.7700837DOI Listing
June 2005

NY-ESO-1 protein expression and humoral immune responses in prostate cancer.

Prostate 2004 Jun;59(4):440-7

Department of Immunology, The Norwegian Radium Hospital, Montebello, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20025DOI Listing
June 2004

Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.

Cancer Immunol Immunother 2004 May 28;53(5):431-8. Epub 2004 Jan 28.

Department of Immunology, Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/16468d9f55fba275dcb08f1e
Web Search
http://link.springer.com/10.1007/s00262-003-0458-8
Publisher Site
http://dx.doi.org/10.1007/s00262-003-0458-8DOI Listing
May 2004

Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments.

FEBS Lett 2004 Apr;563(1-3):7-12

Section for Immunotherapy, University of Oslo at the Norwegian Radium Hospital, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0014-5793(04)00282-0DOI Listing
April 2004

Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresis.

Mutat Res 2003 May;526(1-2):75-83

Department of Immunology, Section for Immunotherapy, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo 0310, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0027-5107(03)00033-2DOI Listing
May 2003

HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.

J Mol Med (Berl) 2003 Jan 13;81(1):43-50. Epub 2002 Nov 13.

Section for Immunotherapy, Department of Immunology, Norwegian Radium Hospital, University of Oslo, Montebello, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-002-0390-yDOI Listing
January 2003

Direct identification of all oncogenic mutants in KRAS exon 1 by cycling temperature capillary electrophoresis.

Electrophoresis 2003 Jan;24(1-2):63-9

Department of Immunology, Section for Immunotherapy The Norweigian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/elps.200390032DOI Listing
January 2003

Population screening of single-nucleotide polymorphisms exemplified by analysis of 8000 alleles.

J Biomol Screen 2002 Dec;7(6):501-6

Department of Surgical Oncology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087057102238623DOI Listing
December 2002

Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.

Anticancer Res 2002 Jan-Feb;22(1A):171-5

Department of Environmental Medicine, The National Institute of Public Health, Oslo, Norway.

View Article

Download full-text PDF

Source
June 2002

Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries.

Anal Biochem 2002 May;304(2):200-5

Section for Immunotherapy, The Norwegian Radium Hospital, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/abio.2002.5629DOI Listing
May 2002

mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT).

J Immunol Methods 2002 Jan;259(1-2):191-203

Section for Immunotherapy, Department of Immunology, The Norwegian Radium Hospital, Cancer Research Institute, University of Oslo, N-0310 Montebello, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-1759(01)00506-3DOI Listing
January 2002